Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 293 results for "Cgix"

Will Cancer Genetics (CGIX) Continue to Surge Higher? - Tale o...

As of late, it has definitely been a great time to be an investor in Cancer Genetics, Inc. (CGIX) . The stock has moved higher by 25.5% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and ... Yahoo! Finance, 5 days ago

5 images for Cgix

Nasdaq, 1 week ago
American Banking News, 1 week ago
Ticker Report, 1 week ago
SleekMoney, 1 month ago
Mideast Time, 1 month ago

InsiderInsights.com Daily Round Up 3/18/15: DO, ASPS, CGIX, ADMA

Mar. 19, 2015 12:55 PM ET | Includes: ADMA, APHB, ASPS, CGIX, DO, DYN, ENOC, FDS, GGP, MMI, MPW, NEE, PCLN, PSA, RGS, RXDX, SANW, SSNC, TCB, TWTR by: InsiderInsights Summary Tables of the top insider purchases and sales filed with the SEC on ...
 Seeking Alpha1 month ago
SPi World News

Cancer Genetics, Inc. Receives New York State Licensure for FHACT® Cervical Cancer Test

RUTHERFORD, N.J., April 16, 2015 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "The Company"), an emerging leader in DNA-based cancer diagnostics, announced today that its proprietary FISH-based HPV-Associated test for cervical ...
 Fierce BioMarkers3 days ago Cancer Genetics, Inc. to Present Results From Three Major Clinical Research Collaborations at USCAP Showcasing the Importance of Genomic Panels for Cancer Identification and Management  Digital Producer4 weeks ago Cancer Genetics' (CGIX) CEO Panna Sharma on Q4 2014 Results - Earnings Call Transcript  Seeking Alpha1 month ago Cancer Genetics to Report Fourth Quarter and Fiscal Year 2014 Financial Results on Thursday, March 1 …  Yahoo! Finance1 month ago
[x]  
Nasdaq

Cancer Genetics (CGIX) Shows Strength: Stock Gains 5.8%

These 7 were hand-picked from the list of 220 Zacks Rank #1 Strong Buys with earnings estimate revisions that are sweeping upward. Their stock prices are expected to rise sooner than the others. Today, this Special Report will be available ...
 Zacks.com1 week ago Cancer Genetics, Inc. (CGIX) in Focus: Stock Jumps 5.3%  Zacks.com1 month ago
[x]  

Leading Health Care Stock for Small-Cap Stars is Cancer Genetics Inc. (CGIX) for February 19

Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars , our proprietary list of small-cap companies with ...
 Equities.com1 month ago

Leading Small-Cap Stars Health Care Stock for April 9 Morning Session is Cancer Genetics Inc. (CGIX)

The world of small-cap health care investing is one of huge booms and major busts. However, equities.com's Small-Cap Stars , our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, helps ...
 Equities.com1 week ago

Janney Montgomery Scott Begins Coverage on Cancer Genetics (CGIX)

Janney Montgomery Scott began coverage on shares of Cancer Genetics (NASDAQ:CGIX) in a report released on Thursday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $13.00 price objective on the stock. Separately, analysts at ...
 SleekMoney1 week ago Cancer Genetics Now Covered by Analysts at Janney Montgomery Scott (CGIX)  American Banking News1 week ago Cancer Genetics Research Coverage Started at Janney Montgomery Scott (CGIX)  Ticker Report1 week ago
Ticker Report

Analysts New Coverage for April, 9th (ADBE, AIV, AKAM, ANET, AVB, CGIX, CNI, CP, CPT, DENN)

Analysts new coverage for Thursday, April 9th: Stephens began coverage on shares of Adobe Systems (NASDAQ:ADBE). They issued an overweight rating on the stock. Janney Montgomery Scott initiated coverage on shares of Apartment Investment and ...
 Ticker Report1 week ago

Cancer Genetics Director John Pappajohn Acquires 50,000 Shares (CGIX)

Cancer Genetics (NASDAQ:CGIX) Director John Pappajohn acquired 50,000 shares of Cancer Genetics stock on the open market in a transaction dated Tuesday, March 17th. The stock was purchased at an average cost of $7.36 per share, with a total value of ...
 SleekMoney1 month ago
SleekMoney

Insider Trading Disclosures for March, 18th (AER, ANGI, APHB, ARX, ASC, AVX, BAS, CBNJ, CGIX, CSE)

Here is a breakdown of insider trading activity for Wednesday, March 18th: Aimia (TSE:AER) insider Financial Corporation Jaguar purchased 5,000 shares of Aimia stock in a transaction that occurred on Tuesday, March 17th. The shares were purchased ...
 SleekMoney1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less